Cisplatin nephrotoxicity affects magnesium and calcium metabolism
Medical and Pediatric Oncology · 2003-09 · 41 (3) · 186-189
DOI: 10.1002/mpo.10335 ↗At a glance
Übersichtsarbeit in Medical and Pediatric Oncology, published online on 2003-07-11. Written by Marshall P Goren. Institution: Department of Urology, The University of Tennessee, Memphis, Tennessee, USA. mgoren@utmem.edu. Cited 45 times so far (Crossref); 42 references. Funded by: PHS HHS.
Abstract (original language)
Cisplatin is not directly toxic to bone, but cisplatin nephrotoxicity leading to magnesium wasting may affect magnesium and calcium metabolism, both of which contribute to bone integrity. The specificity of the magnesium lesion suggests that cisplatin may have an affinity for proteins that regulate magnesium absorption. Sulfhydryls such as amifostine can reduce the toxicity of cisplatin in adults, but current pediatric data do not indicate a role for sulfhydryl therapy to reduce cisplatin toxicity in children. Med Pediatr Oncol 2003;41:186–189, © 2003 Wiley‐Liss, Inc.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Urology, The University of Tennessee, Memphis, Tennessee, USA. mgoren@utmem.edu
Funding
- PHS HHS
Cite
APA
Goren, M. P. (2003). Cisplatin nephrotoxicity affects magnesium and calcium metabolism. Medical and Pediatric Oncology, 41(3), 186-189. https://doi.org/10.1002/mpo.10335
Vancouver
Goren MP. Cisplatin nephrotoxicity affects magnesium and calcium metabolism. Medical and Pediatric Oncology. 2003;41(3):186-189. doi:10.1002/mpo.10335
BibTeX
@article{Goren2003,
author = {Goren, Marshall P},
title = {Cisplatin nephrotoxicity affects magnesium and calcium metabolism},
journal = {Medical and Pediatric Oncology},
year = {2003},
volume = {41},
number = {3},
pages = {186--189},
doi = {10.1002/mpo.10335}
}
EUVIMED